Search research articles
Contact Us
Filters
Showing results (1-10 of 127) with videos related to
Page
of 13
Sort By:
Cell Death and Differentiation
|
December 15, 2020
Engineering organoids: a promising platform to understand biology and treat diseases
Rami I Aqeilan
Cellular and Molecular Life Sciences : CMLS
|
September 21, 2014
Role of common fragile sites and corresponding genes in cancer development
Rami I Aqeilan
Frontiers in Oncology
|
October 30, 2018
Modeling WWOX Loss of Function <i>in vivo</i>: What Have We Learned?
Mayur Tanna, Rami I Aqeilan
Molecular & Cellular Oncology
|
May 12, 2020
Mapping the breakome reveals tight regulation on oncogenic super-enhancers
Sara Oster, Rami I Aqeilan
Experimental Biology and Medicine (Maywood, N.J.)
|
February 11, 2014
WW domain-containing oxidoreductase's role in myriad cancers: clinical significance and future implications
Aliza Gardenswartz, Rami I Aqeilan
Oncotarget
|
April 15, 2017
RUNX1, a new regulator of EMT in breast cancer
Saleh Khawaled, Rami I Aqeilan
Cells
|
August 14, 2020
Programmed DNA Damage and Physiological DSBs: Mapping, Biological Significance and Perturbations in Disease States
Sara Oster, Rami I Aqeilan
Cell Cycle (Georgetown, Tex.)
|
January 16, 2015
T538 phosphorylation, Pin-ing p63-Itch stability
Akram Alian, Rami I Aqeilan
Cells
|
November 27, 2021
WWOX-Related Neurodevelopmental Disorders: Models and Future Perspectives
Daniel J Steinberg, Rami I Aqeilan
Scientific Reports
|
August 11, 2015
Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function
Sara Del Mare, Rami I Aqeilan
Page
of 13
Search research articles
Search
Showing results (1-10 of 127) with videos related to
Sort By:
Page
of 13
Cell Death and Differentiation
|
December 15, 2020
Engineering organoids: a promising platform to understand biology and treat diseases
Rami I Aqeilan
Cellular and Molecular Life Sciences : CMLS
|
September 21, 2014
Role of common fragile sites and corresponding genes in cancer development
Rami I Aqeilan
Frontiers in Oncology
|
October 30, 2018
Modeling WWOX Loss of Function <i>in vivo</i>: What Have We Learned?
Mayur Tanna, Rami I Aqeilan
Molecular & Cellular Oncology
|
May 12, 2020
Mapping the breakome reveals tight regulation on oncogenic super-enhancers
Sara Oster, Rami I Aqeilan
Experimental Biology and Medicine (Maywood, N.J.)
|
February 11, 2014
WW domain-containing oxidoreductase's role in myriad cancers: clinical significance and future implications
Aliza Gardenswartz, Rami I Aqeilan
Oncotarget
|
April 15, 2017
RUNX1, a new regulator of EMT in breast cancer
Saleh Khawaled, Rami I Aqeilan
Cells
|
August 14, 2020
Programmed DNA Damage and Physiological DSBs: Mapping, Biological Significance and Perturbations in Disease States
Sara Oster, Rami I Aqeilan
Cell Cycle (Georgetown, Tex.)
|
January 16, 2015
T538 phosphorylation, Pin-ing p63-Itch stability
Akram Alian, Rami I Aqeilan
Cells
|
November 27, 2021
WWOX-Related Neurodevelopmental Disorders: Models and Future Perspectives
Daniel J Steinberg, Rami I Aqeilan
Scientific Reports
|
August 11, 2015
Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function
Sara Del Mare, Rami I Aqeilan
Page
of 13